Description
Milestones/criteria for down-selection and/or optimization in immunogen design
• At the stage of immunogen design by HMRI & IDDL
• At the stage of transfer of the candidates to SK (i.e. elicitation of neutralizing antibodies and/or expression efficiency)
• Results to date
